We are live on ! Find out more
GLG Partners

GLG Partners Portfolio holdings

AUM $2.14B Turnover 59.22%
1-Year Est. Return 21.14%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$251M
Cap. Flow
-$130M
Cap. Flow %
-6.09%
Top 10 Hldgs %
20.07%
Holding
564
New
243
Increased
78
Reduced
76
Closed
91
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.22%
2 Consumer Discretionary 13.47%
3 Technology 9.7%
4 Financials 9.51%
5 Industrials 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UBSI icon
151
United Bankshares
UBSI
$6.57B
$2.5M 0.12%
+71,927
New +$2.59M
2017 Q4
0 quarters
ILMN icon
152
Illumina
ILMN
$35.6B
$2.49M 0.12%
11,719
+5,243
+81% +$1.08M
2017 Q3
1 quarter
NAV
153
DELISTED
Navistar International
NAV
$2.44M 0.11%
+56,937
New +$2.37M
2017 Q4
0 quarters
ALSN icon
154
Allison Transmission
ALSN
$8.92B
$2.38M 0.11%
+55,168
New +$2.25M
2017 Q4
0 quarters
VR
155
DELISTED
Validus Hold Ltd
VR
$2.35M 0.11%
+50,000
New +$2.47M
2017 Q4
0 quarters
KMX icon
156
CarMax
KMX
$7.89B
$2.34M 0.11%
+36,491
New +$2.6M
2017 Q4
0 quarters
XBI icon
157
State Street SPDR S&P Biotech ETF
XBI
$10.8B
$2.29M 0.11%
26,933
+6,816
+34% +$571K
2017 Q3
1 quarter
SXCP
158
DELISTED
SunCoke Energy Partners, L.P.
SXCP
$2.26M 0.11%
129,528
– –
2016 Q4
4 quarters
HA icon
159
DELISTED
Hawaiian Holdings, Inc.
HA
$2.26M 0.11%
+56,598
New +$2.18M
2017 Q4
0 quarters
ESV
160
DELISTED
Ensco Rowan plc
ESV
$2.25M 0.11%
95,042
-242,471
-72% -$5.37M
2017 Q1
3 quarters
RCL icon
161
Royal Caribbean
RCL
$82.2B
$2.24M 0.1%
+18,744
New +$2.32M
2017 Q4
0 quarters
AGCO icon
162
AGCO
AGCO
$7.65B
$2.23M 0.1%
+31,165
New +$2.22M
2017 Q4
0 quarters
EPC icon
163
Edgewell Personal Care
EPC
$1.32B
$2.2M 0.1%
37,032
-5,962
-14% -$375K
2014 Q4
12 quarters
SVA
164
DELISTED
Sinovac Biotech, Ltd
SVA
$2.14M 0.1%
271,072
-487,787
-64% -$3.65M
2016 Q2
6 quarters
OIH icon
165
VanEck Oil Services ETF
OIH
$1.91B
$2.13M 0.1%
+4,097
New +$2.03M
2017 Q4
0 quarters
PUMP icon
166
ProPetro Holding
PUMP
$950M
$2.13M 0.1%
105,438
-344,694
-77% -$5.84M
2017 Q2
2 quarters
APTV icon
167
Aptiv
APTV
$9.12B
$2.08M 0.1%
24,496
+15,088
+160% +$1.44M
2017 Q3
1 quarter
IR icon
168
Ingersoll Rand
IR
$30.7B
$2.07M 0.1%
61,084
-52,540
-46% -$1.57M
2017 Q2
2 quarters
CALL
169
DELISTED
magicJack VocalTec Ltd
CALL
$2.04M 0.1%
+240,964
New +$1.82M
2017 Q4
0 quarters
FMSA
170
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$2M 0.09%
+383,440
New +$1.81M
2017 Q4
0 quarters
BLUE icon
171
DELISTED
bluebird bio
BLUE
$2M 0.09%
+868
New +$1.76M
2017 Q4
0 quarters
TT icon
172
Trane Technologies
TT
$89.7B
$1.99M 0.09%
22,286
+20,053
+898% +$1.77M
2017 Q3
1 quarter
BIDU icon
173
Baidu
BIDU
$26B
$1.98M 0.09%
8,471
-1,376
-14% -$336K
2015 Q4
8 quarters
KO icon
174
Coca-Cola
KO
$405B
$1.96M 0.09%
+42,803
New +$1.97M
2017 Q4
0 quarters
SMH icon
175
PUT
VanEck Semiconductor ETF
SMH
$65.3B
$1.96M 0.09%
+40,000
New +$1.99M
2017 Q4
0 quarters

Similar funds

GLG Partners's Q4 2017 Portfolio in Review

As of Q4 2017, GLG Partners held 564 positions worth $2.14B, up 13% from $1.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

GLG Partners withdrew a net $130M in Q4 2017, closing 91 positions and reducing 76 holdings. Its most notable exit was Sciclone Pharmaceuticals Inc, an estimated $29M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, GLG Partners opened a new position in Advanced Accelerator Applications S.A. worth $49.2M.

  • GLG Partners's largest Q4 2017 buy was Advanced Accelerator Applications S.A.: 603,055 shares worth $49.2M.
  • GLG Partners added most to NXP Semiconductors in Q4 2017, an estimated $35M increase.
  • GLG Partners's biggest Q4 2017 reduction was Criteo S.A., cutting an estimated $22.5M.
  • GLG Partners fully exited Sciclone Pharmaceuticals Inc in Q4 2017, selling an estimated $29M.
  • GLG Partners's ten largest holdings make up 20% of its $2.14B portfolio in Q4 2017.
  • GLG Partners opened 243 new positions and closed 91 in Q4 2017.
  • GLG Partners's portfolio value rose 13% quarter-over-quarter to $2.14B.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.